{"id":439876,"date":"2010-03-17T11:50:00","date_gmt":"2010-03-17T15:50:00","guid":{"rendered":"http:\/\/techdirt.com\/articles\/20100316\/1732228591.shtml"},"modified":"2010-03-17T11:50:00","modified_gmt":"2010-03-17T15:50:00","slug":"new-study-points-out-that-gene-patent-on-trial-is-very-very-broad","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/439876","title":{"rendered":"New Study Points Out That Gene Patent On Trial Is Very, Very Broad"},"content":{"rendered":"<p>Last year a very important lawsuit was filed, challenging whether or not it was legal to <a href=\"http:\/\/techdirt.com\/articles\/20090513\/0051434857.shtml\">patent genes<\/a>.  While that trial is still (slowly) moving forward, a study has come out pointing out that one of the genes that&#8217;s at the center of that trial, BRCA1, from Myriad Genetics, is <a href=\"http:\/\/www.reuters.com\/article\/idUSTRE62F5YR20100316?feedType=RSS&#038;feedName=healthNews&#038;utm_source=twitterfeed&#038;utm_medium=twitter&#038;utm_campaign=Feed%3A%20reuters%2FhealthNews%20%28News%20%2F%20US%20%2F%20Health%20News%29\" >incredibly broad and could be used to stifle all sorts of important research<\/a>:<\/p>\n<blockquote><p><i><br \/>\nFor instance, BRCA1 is on chromosome 17. But long stretches of DNA on chromosome 1 are identical to stretches in the Myriad patent, the researchers said.<\/p>\n<p>&#8220;This claim and others like it turn out, on examination, to be surprisingly broad, and if enforced would have substantial implications for medical practice and scientific research,&#8221; they wrote.<br \/>\n<\/i><\/p><\/blockquote>\n<p>In the meantime, we&#8217;re still waiting for someone to explain how it possibly makes sense to patent genes.<\/p>\n<p><a href=\"http:\/\/techdirt.com\/articles\/20100316\/1732228591.shtml\">Permalink<\/a> | <a href=\"http:\/\/techdirt.com\/articles\/20100316\/1732228591.shtml#comments\">Comments<\/a> | <a href=\"http:\/\/techdirt.com\/article.php?sid=20100316\/1732228591&#038;op=sharethis\">Email This Story<\/a><br \/>\n <br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<a href=\"http:\/\/ads.pheedo.com\/click.phdo?s=cbddb3e93e7cc05d75eb657d931a60a0&#038;p=1\"><img decoding=\"async\" alt=\"\" style=\"border: 0;\" border=\"0\" src=\"http:\/\/ads.pheedo.com\/img.phdo?s=cbddb3e93e7cc05d75eb657d931a60a0&#038;p=1\"\/><\/a><br \/>\n<!-- foo --><\/p>\n<div class=\"feedflare\">\n<a href=\"http:\/\/feeds.techdirt.com\/~ff\/techdirt\/feed?a=lc2deEj10so:1oH1YFmEi_E:D7DqB2pKExk\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/techdirt\/feed?i=lc2deEj10so:1oH1YFmEi_E:D7DqB2pKExk\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.techdirt.com\/~ff\/techdirt\/feed?a=lc2deEj10so:1oH1YFmEi_E:c-S6u7MTCTE\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/techdirt\/feed?d=c-S6u7MTCTE\" border=\"0\"><\/img><\/a>\n<\/div>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/techdirt\/feed\/~4\/lc2deEj10so\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Last year a very important lawsuit was filed, challenging whether or not it was legal to patent genes. While that trial is still (slowly) moving forward, a study has come out pointing out that one of the genes that&#8217;s at the center of that trial, BRCA1, from Myriad Genetics, is incredibly broad and could be [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-439876","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/439876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=439876"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/439876\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=439876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=439876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=439876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}